BRCA mutations, in either the BRCA1 or BRCA2 gene, are also a well-known category of mutations, as women with harmful mutations in either BRCA1 or BRCA2 are known to have a risk of breast or ovarian cancer that is roughly five to 30 times the normal risk [5]. This evidence concerns the gene BRCA2 and ovarian carcinoma.